RCT of Bumetanide in Hypokalaemic Periodic Paralysis (HypoPP) using abductor digiti minimi compound muscle action potential (CMAP) as an objective outcome measure

Scalco, RS; Morrow, J; Manole, A; Skorupinska, I; Bellin, A; Ricciardi, F; Matthews, E; ... Fialho, D; + view all Scalco, RS; Morrow, J; Manole, A; Skorupinska, I; Bellin, A; Ricciardi, F; Matthews, E; Hanna, M; Fialho, D; - view fewer (2018) RCT of Bumetanide in Hypokalaemic Periodic Paralysis (HypoPP) using abductor digiti minimi compound muscle action potential (CMAP) as an objective outcome measure. Presented at: 11th Annual UK Neuromuscular Translational Research Conference, Cambridge.

https://ift.tt/2joXF1E